
|Podcasts|February 20, 2023
Pharmacy Focus: Oncology Edition - Pharmacists Play Key Role in Non–Small Cell Lung Cancer
Pharmacists can be involved in all aspects of care, from deciding treatment plans to educating patients, and in the growing role of oral treatments.
Advertisement
This month, we spoke with Jennifer Martin, PharmD, BCOP, a hematology-oncology pharmacist with the Allegheny Health Network. Martin said pharmacists can be involved in all aspects of care, from deciding treatment plans to educating patients, and in the growing role of oral treatments.
Interested in learning more? Check out these related articles:
FDA Approves Adjuvant Pembrolizumab for Non–Small Cell Lung Cancer Medicaid Patients With NSCLC May Be Undertreated With Life-Prolonging Targeted Therapies Expert Discusses PD-1 Inhibitors as Treatment of NSCLC New Digital Tool Provides Resources for Patients With Small Cell Lung Cancer and Their Caregivers
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Hypertension Guideline: Key Shifts for Pharmacists
2
Trastuzumab Deruxtecan Superior to Chemoimmunotherapy in HER2-Mutant Advanced NSCLC
3
FDA Approves Autoinjector Device for Lerodalcibep-Liga, Updates Indication to Reflect MACE Risk Reduction
4
Osimertinib, Savolitinib Improve PFS and OS in MET-Driven EGFR-Mutated NSCLC
5






































































































